Cytotoxic Effect of Dose and Schedule on Normal Murine Hematopoietic Progenitor Cells Following the Administration of 4'-deoxydoxorubicin

Overview

Journal Br J Cancer

Specialty Oncology

Date 1984 Nov 1

PMID 6498062

Authors

I PANNACCIULLI

C Muzzulini

G Massa

G Bogliolo

Affiliations

Soon will be listed here.

Abstract

In an experimental setting, 4'-deoxydoxorubicin (4'-deoxy-DX) shows minimal cardiotoxicity as well as the marked antitumoral activity shown by doxorubicin, its parent compound. In this experimental study, the haematologic toxicity of the new anthracycline was investigated by haematopoietic precursor cell (HPC) assays using in vivo (colony-forming units - spleen, CFUs) and in vitro (CFUc-culture) methods with (C57B1 X C3H)F1 mice. Dose-survival curves and time response of HPC in situ following 4'-deoxy-DX administration were determined. In the time-related experiments, the effects of a single dose, an intermittent treatment (Days 0, 2, and 5) and a prolonged biweekly administration were studied. All dose-survival curves were exponential, with statistically significant differences between the effects on the various cell classes. CFUc appeared more sensitive than CFUs. In time-related experiments, 4'-deoxy-DX toxicity for HPC seemed to be relatively mild. However, CFUc sensitivity was again high in comparison with other populations assayed. In long-term administration, the 4-deoxy-DX effects on the haematopoietic system were also rather slight.

References

Buick R, Messner H, Till J, McCulloch E . Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man. J Natl Cancer Inst. 1979; 62(2):249-55. View

Bradley T, Metcalf D . The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966; 44(3):287-99. DOI: 10.1038/icb.1966.28. View

Till J, McCulloch E . A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961; 14:213-22. View

Bonfante V, Bonadonna G, Villani F, Di Fronzo G, Martini A, CASAZZA A . Preliminary phase I study of 4'-epi-adriamycin. Cancer Treat Rep. 1979; 63(5):915-8. View

Giuliani F, Zirvi K, Kaplan N, Goldin A . Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin. Int J Cancer. 1981; 27(1):5-13. DOI: 10.1002/ijc.2910270103. View

Sobrero A, Muzzulini C, DAmore F, Bogliolo G, Massa G, Ghio R . Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in mice. Cancer Treat Rep. 1982; 66(12):2061-70. View

Huybrechts M, Symann M, Trouet A . Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells. Cancer Res. 1979; 39(9):3738-43. View

LAJTHA L . Haemopoietic stem cells. Br J Haematol. 1975; 29(4):529-35. DOI: 10.1111/j.1365-2141.1975.tb02739.x. View

Salmon S, Liu R, CASAZZA A . Evaluation of new anthracycline analogs with the human tumor stem cell assay. Cancer Chemother Pharmacol. 1981; 6(2):103-9. DOI: 10.1007/BF00262325. View

10.

ARCAMONE F, Penco S, Redaelli S, Hanessian S . Synthesis and antitumor activity of 4'-deoxydaunorubicin and 4'-deoxyadriamycin. J Med Chem. 1976; 19(12):1424-5. DOI: 10.1021/jm00234a016. View

11.

PANNACCIULLI I, Massa G, Bogliolo G, Ghio R, Sobrero A . Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells. Cancer Res. 1982; 42(2):530-4. View

12.

Giuliani F, Kaplan N . New doxorubicin analogs active against doxorubicin-resistant colon tumor xenografts in the nude mouse. Cancer Res. 1980; 40(12):4682-7. View

13.

Marsh J . Comparison of the sensitivities of human, canine, and murine hematopoietic precursor cells to adriamycin and N-trifluoroacetyladriamycin-14-valerate. Cancer Res. 1979; 39(2 Pt 1):360-4. View

14.

Razek A, Valeriote F, VIETTI T . Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin. Cancer Res. 1972; 32(7):1496-500. View

15.

Marsh J . The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review. Cancer Res. 1976; 36(6):1853-82. View

16.

Massa G, Bogliolo G, DAmore F, Muzzulini C, Ghio R, PANNACCIULLI I . Hematopoietic precursor cells in mice treated with 4-demethoxydaunorubicin and doxorubicin. J Natl Cancer Inst. 1982; 68(6):971-6. View

17.

BLACKETT N, Marsh J, Gordon M, Okell S, Aguado M . Simultaneous assay by six methods of the effect on haemopoietic precursor cells of adriamycin, methyl CCNU, 60Co gamma-rays, vinblastine, and cytosine arabinoside. Exp Hematol. 1978; 6(1):2-8. View

18.

Muzzulini C, DAmore F, Sobrero A, Massa G, Bogliolo G, Ghio R . [Evaluation of doxorubicin toxicity on normal hemopoietic stem cells]. Tumori. 1981; 67(4):293-300. DOI: 10.1177/030089168106700405. View

19.

Plumbridge T, Brown J . The interaction of adriamycin and adriamycin analogues with nucleic acids in the B and A conformations. Biochim Biophys Acta. 1979; 563(1):181-92. DOI: 10.1016/0005-2787(79)90019-4. View

20.

Page P, Cook P, Greenberg H, Hartwell B, ROBINSON S . Cytotoxic reduction and regeneration of murine marrow stem cells. Exp Hematol. 1983; 11(3):202-11. View